article virus infection caused virus hivaids uses disambiguation
aids virus redirects computer virus aids computer virus


human immunodeficiency virus





scanning electron micrograph hiv1 green budding cultured lymphocyte multiple round bumps cell surface represent sites assembly budding virions


virus classification


group
group ssrnart


order
unassigned


family
retroviridae


subfamily
orthoretrovirinae


genus
lentivirus


species




human immunodeficiency virus
human immunodeficiency virus




human immunodeficiency virus lentivirus subgroup retrovirus causes infection time acquired immunodeficiency syndrome aids12 aids condition humans progressive failure immune system allows lifethreatening opportunistic infections cancers thrive without treatment average survival time infection estimated years depending subtype3 cases sexually transmitted infection occurs contact transfer blood preejaculate semen vaginal fluids nonsexual transmission occur infected mother infant breast milk456 hivpositive mother transmit baby pregnancy childbirth exposure blood vaginal fluid7 within bodily fluids present free virus particles virus within infected immune cells
infects vital cells human immune system helper cells specifically cells macrophages dendritic cells8 infection leads levels cells number mechanisms including pyroptosis abortively infected cells9 apoptosis uninfected bystander cells10 direct viral killing infected cells killing infected cells cytotoxic lymphocytes recognize infected cells11 cell numbers decline critical level cellmediated immunity lost body becomes progressively susceptible opportunistic infections leading development aids



contents


virology

classification
structure genome
tropism
replication cycle

entry cell
replication transcription
recombination
assembly release


spread within body
genetic variability


diagnosis
research
treatment
history

discovery
origins


also
references
reading
external links



virology
classification
also subtypes

comparison species

species
virulence
infectivity
prevalence
inferred origin


hiv1
high
high
global
common chimpanzee


hiv2
lower

west africa
sooty mangabey


member genus lentivirus12 part family retroviridae13 lentiviruses many morphologies biological properties common many species infected lentiviruses characteristically responsible longduration illnesses long incubation period14 lentiviruses transmitted singlestranded positivesense enveloped viruses upon entry target cell viral genome converted reverse transcribed doublestranded virally encoded enzyme reverse transcriptase transported along viral genome virus particle resulting viral imported cell nucleus integrated cellular virally encoded enzyme integrase host cofactors15 integrated virus become latent allowing virus host cell avoid detection immune system indiscriminate amount time16 virus remain dormant human body years primary infection period virus cause symptoms alternatively integrated viral transcribed producing genomes viral proteins using host cell resources packaged released cell virus particles begin replication cycle anew
types characterized hiv1 hiv2 hiv1 virus initially discovered termed lymphadenopathy associated virus htlviii human cell lymphotropic virus hiv1 virulent infective hiv217 cause majority infections globally lower infectivity hiv2 compared hiv1 implies fewer exposed hiv2 infected exposure relatively poor capacity transmission hiv2 largely confined west africa18
structure genome
main article structure genome




diagram virion


different structure retroviruses roughly spherical19 diameter around times smaller blood cell20 composed copies positivesense singlestranded codes viruss nine genes enclosed conical capsid composed 2000 copies viral protein p2421 singlestranded tightly bound nucleocapsid proteins enzymes needed development virion reverse transcriptase proteases ribonuclease integrase matrix composed viral protein surrounds capsid ensuring integrity virion particle21
turn surrounded viral envelope composed lipid bilayer taken membrane human host cell newly formed virus particle buds cell viral envelope contains proteins host cell relatively copies envelope protein21 consists made three molecules known glycoprotein stem consisting three gp41 molecules anchor structure viral envelope2223 envelope protein encoded gene allows virus attach target cells fuse viral envelope target cells membrane releasing viral contents cell initiating infectious cycle22
sole viral protein surface virus envelope protein major target vaccine efforts24 half mass trimeric envelope spike nlinked glycans density high glycans shield underlying viral protein neutralisation antibodies densely glycosylated molecules known density sufficiently high prevent normal maturation process glycans biogenesis endoplasmic golgi apparatus2526 majority glycans therefore stalled immature highmannose glycans normally present human glycoproteins secreted present cell surface27 unusual processing high density means almost broadly neutralising antibodies identified subset patients infected many months years bind adapted cope envelope glycans28
molecular structure viral spike determined xray crystallography29 cryoelectron microscopy30 advances structural biology made possible development stable recombinant forms viral spike introduction intersubunit disulphide bond isoleucine proline mutation gp4131 socalled sosip trimers reproduce antigenic properties native viral spike also display degree immature glycans presented native virus32 recombinant trimeric viral spikes promising vaccine candidates display less nonneutralising epitopes recombinant monomeric gp120 suppress immune response target epitopes33




structure genome hiv1


genome consists least seven structural landmarks slip nine genes sometimes tenth fusion encoding proteins three genes contain information needed make structural proteins virus particles21 example codes protein called gp160 cellular protease form gp120 gp41 remaining genes case hiv2 regulatory genes proteins control ability infect cells produce copies virus replicate cause disease21
proteins transcriptional transactivators promoter acting binding element also processed micrornas regulate apoptosis genes ercc1 ier33435 protein involved shuttling rnas nucleus cytoplasm binding element protein prevents action apobec3g cellular protein deaminates cytidine uridine single stranded viral andor interferes reverse transcription36 protein arrests cell division protein downregulates major viral receptor well class class molecules373839
also interacts domains protein influences release virus particles infected cells21 ends strand contain sequence called long terminal repeat regions switches control production viruses triggered proteins either host cell element involved viral genome packaging recognized proteins slip element tttttt involved frameshift gagpol reading frame required make functional pol21
tropism
main article tropism




diagram immature mature forms


term viral tropism refers cell types virus infects infect variety immune cells cells macrophages microglial cells hiv1 entry macrophages cells mediated interaction virion envelope glycoproteins gp120 molecule target cells membrane also chemokine coreceptors2240
macrophagetropic mtropic strains hiv1 nonsyncytiainducing strains called viruses41 βchemokine receptor ccr5 entry thus able replicate macrophages cells42 ccr5 coreceptor used almost primary hiv1 isolates regardless viral genetic subtype indeed macrophages play role several critical aspects infection appear first cells infected perhaps source production cells become depleted patient macrophages microglial cells cells infected central nervous system tonsils adenoids hivinfected patients macrophages fuse multinucleated giant cells produce huge amounts virus
ttropic strains hiv1 syncytiainducing called viruses41 strains replicate primary cells well macrophages αchemokine receptor cxcr4 entry424344
dualtropic hiv1 strains thought transitional strains hiv1 thus able ccr5 cxcr4 coreceptors viral entry
αchemokine sdf1 ligand cxcr4 suppresses replication ttropic hiv1 isolates downregulating expression cxcr4 surface target cells mtropic hiv1 isolates ccr5 receptor termed cxcr4 termed x4r5 however coreceptor alone explain viral tropism viruses able ccr5 macrophages productive infection42 also infect subtype myeloid dendritic cells45 probably constitute reservoir maintains infection cell numbers declined extremely levels
people resistant certain strains hiv46 example people ccr5δ32 mutation resistant infection virus mutation leaves unable bind coreceptor reducing ability infect target cells
sexual intercourse major mode transmission present seminal fluid enables virus transmitte male sexual partner virions infect numerous cellular targets disseminate whole organism however selection process leads predominant transmission virus pathway474849 patients infected subtype hiv1 often coreceptor switch latestage disease ttropic variants infect variety cells cxcr450 variants replicate aggressively heightened virulence causes rapid cell depletion immune system collapse opportunistic infections mark advent aids51 thus course infection viral adaptation cxcr4 instead ccr5 step progression aids number studies subtype binfected individuals determined percent aids patients harbour viruses presumed phenotypes5253
hiv2 much less pathogenic hiv1 restricted worldwide distribution west africa adoption accessory genes hiv2 promiscuous pattern coreceptor usage including cd4independence assist virus adaptation avoid innate restriction factors present host cells adaptation normal cellular machinery enable transmission productive infection also aided establishment hiv2 replication humans survival strategy infectious agent kill host ultimately become commensal organism achieved pathogenicity time variants successful transmission selected54
replication cycle




replication cycle


entry cell




mechanism viral entry initial interaction gp120 conformational change gp120 allows secondary interaction ccr5 distal tips gp41 inserted cellular membrane gp41 undergoes significant conformational change folding half forming coiledcoils process pulls viral cellular membranes together fusing


virion enters macrophages cells adsorption glycoproteins surface receptors target cell followed fusion viral envelope target cell membrane release capsid cell5556
entry cell begins interaction trimeric envelope complex gp160 spike viral envelope chemokine coreceptor generally either ccr5 cxcr4 others known interact target cell surface5556 gp120 binds integrin α4β7 activating lfa1 central integrin involved establishment virological synapses facilitate efficient celltocell spreading hiv157 gp160 spike contains binding domains chemokine receptors5556
first step fusion involves highaffinity attachment binding domains gp120 gp120 bound protein envelope complex undergoes structural change exposing chemokine receptor binding domains gp120 allowing interact target chemokine receptor5556 allows stable twopronged attachment allows nterminal fusion peptide gp41 penetrate cell membrane5556 repeat sequences gp41 interact causing collapse extracellular portion gp41 hairpin loop structure brings virus cell membranes close together allowing fusion membranes subsequent entry viral capsid5556
bound target cell various enzymes including reverse transcriptase integrase ribonuclease protease injected cell55not citation given microtubulebased transport nucleus viral singlestrand genome transcribed doublestrand integrated host chromosome
infect dendritic cells cd4ccr5 route another route using mannosespecific ctype lectin receptors dcsign also used58 first cells encountered virus sexual transmission currently thought play important role transmitting tcells virus captured mucosa dcs58 presence fez1 occurs naturally neurons believed prevent infection cells hiv59




clathrindependent endocytosis


hiv1 entry well entry many retroviruses long believed occur exclusively plasma membrane recently however productive infection phindependent clathrindependent endocytosis hiv1 also reported recently suggested constitute route productive entry6061626364
replication transcription




reverse transcription genome doublestranded


shortly viral capsid enters cell enzyme called reverse transcriptase liberates positivesense singlestranded genome attached viral proteins copies complementary cdna molecule65 process reverse transcription extremely errorprone resulting mutations cause drug resistance allow virus evade bodys immune system reverse transcriptase also ribonuclease activity degrades viral synthesis cdna well dnadependent polymerase activity creates sense antisense cdna66 together cdna complement form doublestranded viral transported cell nucleus integration viral host cells genome carried another viral enzyme called integrase65
integrated viral dormant latent stage infection65 actively produce virus certain cellular transcription factors need present important nfκb nuclear factor kappa upregulated cells become activated67 means cells likely targeted entered subsequently killed currently fighting infection
viral replication integrated provirus transcribed undergo splicing produce mature mrnas mrnas exported nucleus cytoplasm translated regulatory proteins encourages virus production newly produced protein produced moves nucleus binds fulllength unspliced copies virus rnas allows leave nucleus68 fulllength rnas function copies virus genome others function mrnas translated produce structural proteins proteins bind copies virus genome package virus particles69
hiv1 hiv2 appear package differently70citation needed hiv1 bind appropriate rnacitation needed hiv2 preferentially bind mrna used create protein itself71
recombination
genomes encapsidated hiv1 particle structure genome upon infection replication catalyzed reverse transcriptase recombination genomes occur7273 recombination occurs singlestrand genomes reverse transcribed form reverse transcription nascent switch multiple times copies viral form recombination known copychoice recombination events occur throughout genome anywhere recombination events genome occur replication cycle events rapidly shuffle genetic information transmitted parental progeny genomes73
viral recombination produces genetic variation likely contributes evolution resistance antiretroviral therapy74 recombination also contribute principle overcoming immune defenses host adaptive advantages genetic variation realized viral genomes packaged individual infecting virus particles need arisen separate progenitor parental viruses differing genetic constitution unknown often mixed packaging occurs natural conditions75
bonhoeffer al76 suggested template switching reverse transcriptase acts repair process deal breaks singlestranded genome addition temin72 suggested recombination adaptation repair damage genomes strand switching copychoice recombination reverse transcriptase could generate undamaged copy genomic damaged singlestranded genome copies view adaptive benefit recombination could explain particle contains complete genomes rather furthermore view recombination repair process implies benefit repair occur replication cycle benefit realized whether genomes differ genetically view recombination repair process generation recombinational variation would consequence cause evolution template switching76
hiv1 infection causes chronic ongoing inflammation production reactive oxygen species77 thus genome vulnerable oxidative damages including breaks singlestranded well viruses generally successful infection depends overcoming host defensive strategies often include production genomedamaging reactive oxygen thus michod al78 suggested recombination viruses adaptation repair genome damages recombinational variation byproduct provide separate benefit
assembly release




assembling surface infected macrophage virions marked green fluorescent viewed fluorescent microscope


final step viral cycle assembly hiv1 virions begins plasma membrane host cell polyprotein gp160 goes endoplasmic reticulum transported golgi complex cleaved furin resulting envelope glycoproteins gp41 gp12079 transported plasma membrane host cell gp41 anchors gp120 membrane infected cell gagpol p160 polyproteins also associate inner surface plasma membrane along genomic forming virion begins host cell budded virion still immature polyproteins still need cleaved actual matrix capsid nucleocapsid proteins cleavage mediated packaged viral protease inhibited antiretroviral drugs protease inhibitor class various structural components assemble produce mature virion80 mature virions able infect another cell
spread within body
known spread cells parallel routes cellfree spread celltocell spread employs hybrid spreading mechanisms81 cellfree spread virus particles infected cell enter blood extracellular fluid infect another cell following chance encounter81 also disseminate direct transmission cell another process celltocell spread pathways celltocell transmission reported firstly infected cell transmit virus directly target cell virological synapse5782 secondly antigenpresenting cell macrophages dendritic cells also transmit cells process either involves productive infection case macrophages capture transfer virions trans case dendritic cells83 whichever pathway used infection celltocell transfer reported much efficient cellfree virus spread84 number factors contribute increased efficiency including polarised virus budding towards site celltocell contact close apposition cells minimizes fluidphase diffusion virions clustering entry receptors target cell contact zone82 celltocell spread thought particularly important lymphoid tissues cells densely packed likely frequently interact81 intravital imaging studies supported concept virological synapse vivo85 hybrid spreading mechanisms contribute virus ongoing replication antiretroviral therapies8186
genetic variability
information subtypes




phylogenetic tree


differs many viruses high genetic variability diversity result fast replication cycle generation 1010 virions every coupled high mutation rate approximately 10−5 nucleotide base cycle replication recombinogenic properties reverse transcriptase878889
complex scenario leads generation many variants single infected patient course day87 variability compounded single cell simultaneously infected different strains simultaneous infection occurs genome progeny virions composed strands different strains hybrid virion infects cell undergoes replication happens reverse transcriptase jumping back forth different templates generate newly synthesized retroviral sequence recombinant parental genomes87 recombination obvious occurs subtypes87
closely related simian immunodeficiency virus evolved many strains classified natural host species strains african green monkey sivagm sooty mangabey sivsmm thought long evolutionary history hosts hosts adapted presence virus90 present high levels hosts blood evokes mild immune response91 cause development simian aids92 undergo extensive mutation recombination typical infection humans93
contrast strains infect species adapted heterologous similar hosts rhesus cynomologus macaques animals develop aids virus generates genetic diversity similar seen human infection94 chimpanzee sivcpz closest genetic relative hiv1 associated increased mortality aidslike symptoms natural host95 sivcpz appears transmitted relatively recently chimpanzee human populations hosts adapted virus90 virus also lost function gene present sivs nonpathogenic variants suppresses cell activation marker nefs function nonpathogenic forms downregulate expression inflammatory cytokines mhc1 signals affect cell trafficking hiv1 sivcpz inhibit tcell activation lost function without function cell depletion likely leading immunodeficiency9596
three groups hiv1 identified basis differences envelope region group prevalent subdivided eight subtypes clades based whole genome geographically distinct98 prevalent subtypes found mainly north america europe found mainly africa found mainly africa asia subtypes form branches phylogenetic tree representing lineage group hiv1 coinfection distinct subtypes gives rise circulating recombinant forms crfs 2000 last year analysis global subtype prevalence made infections worldwide subtype subtype acrf02ag subtype subtype crfae remaining composed subtypes crfs99 hiv1 research focused subtype laboratories focus subtypes100 existence fourth group hypothesised based virus isolated 2009101 strain apparently derived gorilla sivgor first isolated western lowland gorillas 2006101
hiv2s closest relative sivsm strain found sooty mangabees since hiv1 derived sivcpz hiv2 sivsm genetic sequence hiv2 partially homologous hiv1 closely resembles sivsmcitation needed102
diagnosis
main article diagnosis hivaids




generalized graph relationship copies viral load counts average course untreated infection particular individuals disease course vary considerably
cell count cells
copies plasma



many hivpositive people unaware infected virus103 example 2001 less sexually active urban population africa tested proportion even lower rural populations103 furthermore 2001 pregnant women attending urban health facilities counselled tested receive test results103 proportion even lower rural health facilities103 since donors therefore unaware infection donor blood blood products used medicine medical research routinely screened hiv104
hiv1 testing initially done using enzymelinked immunosorbent assay elisa detect antibodies hiv1 specimens nonreactive result initial elisa considered hivnegative unless exposure infected partner partner unknown status occurred specimens reactive elisa result retested duplicate105 result either duplicate test reactive specimen reported repeatedly reactive undergoes confirmatory testing specific supplemental test polymerase chain reaction western blot less commonly immunofluorescence assay specimens repeatedly reactive elisa positive reactive western blot considered hivpositive indicative infection specimens repeatedly elisareactive occasionally provide indeterminate western blot result either incomplete antibody response infected person nonspecific reactions uninfected person106






























deaths 2014107
nigeria 1576
south africa 1251
india 1150
tanzania 4169
mozambique 4061
zimbabwe
cameroon
indonesia
kenya
uganda
malawi
congo
ethiopia
2921



although used confirm infection ambiguous cases assay widely used general second specimen collected month later retested persons indeterminate western blot results although much less commonly available nucleic acid testing viral proviral amplification method also help diagnosis certain situations105 addition tested specimens might provide inconclusive results quantity specimen situations second specimen collected tested infection
modern testing extremely accurate single screening test correct time108needs update chance falsepositive result standard twostep testing protocol estimated 250000 risk population108 testing postexposure recommended immediately weeks three months months109
latest recommendations show testing must start immunoassay combination test hiv1 hiv2 antibodies antigen negative result rules exposure positive must followed hiv12 antibody differentiation immunoassay detect antibodies present gives rise four possible scenarios

hiv1 hiv2 hiv1 antibodies detected
hiv1 hiv2 hiv2 antibodies detected
hiv1 hiv2 hiv1 hiv2 antibodies detected
hiv1 indeterminate hiv2 nucleic acid test must carried detect acute infection hiv1 absence110

updated algorithm published june 2014 recommends diagnosis starts antigen test negative result rules infection positive must followed hiv12 antibody differentiation immunoassay positive differentiation test confirms diagnosis negative indeterminate result must followed nucleic acid test positive result confirms hiv1 infection whereas negative result rules infection false positive p24111
research
main article hivaids research
hivaids research includes medical research attempts prevent treat cure hivaids well fundamental research nature infectious agent aids disease caused
many governments research institutions participate hivaids research research includes behavioral health interventions research education drug development research microbicides sexually transmitted diseases vaccines antiretroviral drugs112 medical research areas include topics preexposure prophylaxis postexposure prophylaxis circumcision accelerated aging effects
many years research untested vaccine created113 bispecific antibodies target surface tcells viral epitopes prevent entry virus human cells114 another group utilised technology develop bispecific antibody neutralises viral particles crosslinking envelope glycoproteins115
treatment
main article management hivaids
latency consequent viral reservoir cells dendritic cells well macrophages main barrier eradication virus16
important note although highly virulent transmission greatly reduced hivinfected person suppressed undetectable viral load copiesml prolonged successful antiretroviral treatment hence said almost impossible still nonzero hivinfected person undetectable viral load transmit virus even unprotected sexual intercourse would negligible amount present seminal fluid vaginal secretions blood transmission occur116117 mean however prolonged antiretroviral treatment result suppressed viral load undetectable viral load generally agreed less copies milliliter blood proven polymerase chain reaction test118
time important recognise reaching undetectable viral load determined many factors including treatment adherence resistance certain antiretroviral drugs stigma inadequate health systems119
history
main article history hivaids
discovery
aids first clinically observed 1981 united states120 initial cases cluster injection drug users known cause impaired immunity showed symptoms pneumocystis carinii pneumonia rare opportunistic infection known occur people compromised immune systems121 soon thereafter additional developed previously rare skin cancer called kaposis sarcoma ks122123 many cases emerged alerting centers disease control prevention task force formed monitor outbreak124 earliest retrospectively described case aids believed norway beginning 1966125
beginning official name disease often referring diseases associated example lymphadenopathy disease discoverers originally named virus126127 also used kaposis sarcoma opportunistic infections name task force 1981128 general press term grid stood gayrelated immune deficiency coined129 search name looking infected communities coined disease seemed single homosexuals heroin users hemophiliacs haitians130131 however determining aids isolated community128 realized term grid misleading aids introduced meeting july 1982132 september 1982 started using name aids133




robert gallo codiscoverer


1983 separate research groups robert gallo montagnier independently declared novel retrovirus infecting aids patients published findings issue journal science134135 gallo claimed virus group isolated person aids strikingly similar shape human tlymphotropic viruses htlvs group first isolate gallos group called newly isolated virus htlviii time montagniers group isolated virus patient presenting swelling lymph nodes neck physical weakness classic symptoms aids contradicting report gallos group montagnier colleagues showed core proteins virus immunologically different htlvi montagniers group named isolated virus lymphadenopathyassociated virus lav124 viruses turned 1986 htlviii renamed hiv136
another group working contemporaneously montagnier gallo groups levy university california francisco independently discovered aids virus 1983 named aids associated retrovirus arv137 virus different virus reported montagnier gallo groups strains indicated first time heterogeneity isolates several remain classic examples aids virus found united states138
origins
hiv1 hiv2 believed originated nonhuman primates westcentral africa believed transferred humans process known zoonosis early 20th century139140
hiv1 appears originated southern cameroon evolution sivcpz simian immunodeficiency virus infects wild chimpanzees hiv1 descends sivcpz endemic chimpanzee subspecies troglodytes troglodytes141142 closest relative hiv2 virus sooty mangabey cercocebus atys atys world monkey living littoral west africa southern senegal western côte divoire18 world monkeys monkey resistant hiv1 infection possibly genomic fusion viral resistance genes143 hiv1 thought jumped species barrier least three separate occasions giving rise three groups virus o144




left right african green monkey source sooty mangabey source hiv2 chimpanzee source hiv1


evidence humans participate bushmeat activities either hunters bushmeat vendors commonly acquire siv145 however weak virus typically suppressed human immune system within weeks infection thought several transmissions virus individual individual quick succession necessary allow enough time mutate hiv146 furthermore relatively persontoperson transmission rate spread throughout population presence highrisk transmission channels thought absent africa prior 20th century
specific proposed highrisk transmission channels allowing virus adapt humans spread throughout society depend proposed timing animaltohuman crossing genetic studies virus suggest recent common ancestor hiv1 group dates back circa 1910147 proponents dating link epidemic emergence colonialism growth large colonial african cities leading social changes including different patterns sexual contact especially multiple concurrent partnerships spread prostitution concomitant high frequency genital ulcer diseases syphilis nascent colonial cities148 transmission rates vaginal intercourse typically increased many fold partners suffers sexually transmitted infection resulting genital ulcers early 1900s colonial cities notable high prevalence prostitution genital ulcers degree 1928 many female residents eastern leopoldville thought prostitutes 1933 around residents city infected forms syphilis148
alternative view unsupported evidence holds unsafe medical practices africa years following world unsterile reuse singleuse syringes mass vaccination antibiotic antimalaria treatment campaigns initial vector allowed virus adapt humans spread146149150
earliest welldocumented case human dates back 1959 belgian congo151 virus present united states early midtolate 1950s sixteenyearold male presented symptoms 1966 died 1969152
also


medicine portal
viruses portal



antiviral drug
discovery development hivprotease inhibitors
hivaids denialism
world aids

references


weiss 1993 cause aids science 5112 1273–9 bibcode1993sci2601273w doi101126science8493571 pmid 8493571
douek roederer koup 2009 emerging concepts immunopathogenesis aids annual review medicine 471–84 doi101146annurevmed60041807123549 2716400 pmid 18947296
unaids december 2007 2007 aids epidemic update retrieved 20080312
mabuka nduati odemdavis peterson overbaugh 2012 desrosiers hivspecific antibodies capable adcc common breastmilk associated reduced risk transmission women high viral loads plos pathogens e1002739 doi101371journalppat1002739 3375288 pmid 22719248
hahn robert inhorn marcia claire 2009 anthropology public health bridging differences culture society oxford oxford university press isbn 9780195374643 oclc 192042314
mead 2008 contaminants human milk weighing risks benefits breastfeeding environmental health perspectives a426–34 doi101289ehp116a426 2569122 pmid 18941560 archived original november 2008
preventing mothertochild transmission hivgov retrieved 20171208 article incorporates text source public domain
cunningham donaghy harman turville 2010 manipulation dendritic cell function viruses current opinion microbiology 524–529 doi101016jmib201006002 pmid 20598938
doitsh gilad galloway nicole geng yang zhiyuan monroe kathryn zepeda orlando hunt peter hatano hiroyu sowinski stefanie muñozarias greene warner 2014 cell death pyroptosis drives tcell depletion hiv1 infection nature 7484 509–514 doi101038nature12940 4047036 pmid 24356306
garg mohl joshi 2012 hiv1 induced bystander apoptosis viruses 3020–43 doi103390v4113020 3509682 pmid 23202514
kumar vinay 2012 robbins basic pathology isbn 9781455737871
international committee taxonomy viruses 2002 6106 lentivirus national institutes health retrieved february 2006
international committee taxonomy viruses 2002 retroviridae national institutes health retrieved february 2006
levy 1993 pathogenesis longterm survival aids 1401–10 doi1010970000203019931100000001 pmid 8280406
smith daniel 2006 following path virus exploitation host repair mechanisms retroviruses chemical biology 217–26 doi101021cb600131q pmid 17163676
latency 2011 httpswwwncbinlmnihgovpmcarticlespmc3234450 accessed december 2017 cold spring harb perspect a007096
gilbert mckeague eisen mullins guéyendiaye mboup kanki february 2003 comparison hiv1 hiv2 infectivity prospective cohort study senegal statistics medicine 573–593 doi101002sim1342 pmid 12590415
reeves doms 2002 human immunodeficiency virus type journal general virology 1253–65 doi101099002213178361253 pmid 12029140
mcgovern caselli grigorieff shoichet 2002 common mechanism underlying promiscuous inhibitors virtual highthroughput screening journal medicinal chemistry 1712–22 doi101021jm010533y pmid 11931626
compared overview fisher bruce harvey richard champe pamela 2007 lippincotts illustrated reviews microbiology lippincotts illustrated reviews hagerstown lippincott williams wilkins isbn 0781782155
various 2008 sequence compendium 2008 introduction retrieved march 2009
chan fass berger 1997 core structure gp41 envelope glycoprotein cell 263–73 doi101016s0092867400802056 pmid 9108481
klein joshua bjorkman pamela rall glenn 2010 evading antibody avidity plos pathogens e1000908 doi101371journalppat1000908 2877745 pmid 20523901
national institute health june 1998 crystal structure protein reveals prevention treatment targets press release archived original february 2006 retrieved september 2006
behrens annajanina vasiljevic snezana pritchard laura harvey david andev rajinder krumm stefanie struwe weston cupo albert kumar abhinav zitzmann nicole seabright gemma kramer holger spencer daniel royle louise jeong hyun klasse burton dennis wilson ward andrew sanders rogier moore john doores katie crispin 2016 composition antigenic effects individual glycan sites trimeric hiv1 envelope glycoprotein cell reports 2695–706 doi101016jcelrep201602058 4805854 pmid 26972002
pritchard laura spencer daniel royle louise bonomelli camille seabright gemma behrens annajanina kulp daniel menis sergey krumm stefanie dunlop cameron crispin daniel bowden thomas scanlan christopher ward andrew schief william doores katie crispin 2015 glycan clustering stabilizes mannose patch hiv1 preserves vulnerability broadly neutralizing antibodies nature communications 7479 bibcode2015natco6e7479p doi101038ncomms8479 4500839 pmid 26105115
pritchard laura harvey david bonomelli camille crispin doores katie 2015 cell proteindirected glycosylation native cleaved hiv1 envelope journal virology 8932–44 doi101128jvi0119015 4524065 pmid 26085151
crispin doores katie 2015 targeting hostderived glycans enveloped viruses antibodybased vaccine design current opinion virology 63–9 doi101016jcoviro201502002 4827424 pmid 25747313
julien jeanphilippe cupo albert devin stanfield robyn lyumkis dmitry deller marc klasse perjohan burton dennis sanders rogier 20131220 crystal structure soluble cleaved hiv1 envelope trimer science 6165 1477–1483 doi101126science1245625 issn 10959203 3886632 pmid 24179159
lyumkis dmitry julien jeanphilippe natalia cupo albert potter clinton klasse perjohan burton dennis sanders rogier moore john 20131220 cryoem structure fully glycosylated soluble cleaved hiv1 envelope trimer science 6165 1484–1490 doi101126science1245627 issn 10959203 3954647 pmid 24179160
sanders rogier derking ronald cupo albert julien jeanphilippe yasmeen anila natalia helen blattner claudia peña alba torrents 20130901 nextgeneration cleaved soluble hiv1 trimer bg505 sosip664 gp140 expresses multiple epitopes broadly neutralizing nonneutralizing antibodies plos pathogens e1003618 doi101371journalppat1003618 issn 15537374 3777863 pmid 24068931
pritchard laura vasiljevic snezana ozorowski gabriel seabright gemma cupo albert ringe rajesh helen sanders rogier doores katie 20150616 structural constraints determine glycosylation hiv1 envelope trimers cell reports 1604–1613 doi101016jcelrep201505017 issn 22111247 4555872 pmid 26051934
taeye steven ozorowski gabriel torrents peña alba guttman miklos julien jeanphilippe kerkhof burger judith pritchard laura pugach pavel 20151217 immunogenicity stabilized hiv1 envelope trimers reduced exposure nonneutralizing epitopes cell 1702–1715 doi101016jcell201511056 issn 10974172 4732737 pmid 26687358
ouellet plante landry barat janelle flamand tremblay provost april 2008 identification functional micrornas released asymmetrical processing hiv1 element nucleic acids research 2353–65 doi101093nargkn076 2367715 pmid 18299284
klase winograd davis carpio hildreth heydarian mccaffrey meiri ayashrashkovsky gilad bentwich kashanchi 2009 hiv1 mirna protects apoptosis altering cellular gene expression retrovirology doi10118617424690618 2654423 pmid 19220914
vasudevan smits höppner häussinger koenig münk 2013 structural features antiviral cytidine deaminases biological chemistry 1357–70 doi101515hsz20130165 pmid 23787464
garcia miller april 1991 serine phosphorylationindependent downregulation cellsurface nature 6318 508–11 bibcode1991natur350508g doi101038350508a0 pmid 2014052
schwartz maréchal gall lemonnier heard march 1996 endocytosis major histocompatibility complex class molecules induced hiv1 protein nature medicine 338–42 doi101038nm0396338 pmid 8612235
stumptnercuvelette morchoisne dugast gall raposo schwartz benaroch october 2001 hiv1 impairs class antigen presentation surface expression proceedings national academy sciences united states america 12144–9 bibcode2001pnas9812144s doi101073pnas221256498 59782 pmid 11593029
arrildt kathryn twigg joseph sarah beth swanstrom ronald march 2012 hiv1 protein coat many colors current hivaids reports current hivaids reports 53–63
berger doms fenyö korber littman moore sattentau schuitemaker sodroski weiss 1998 classification hiv1 nature 6664 bibcode1998natur391240b doi10103834571 pmid 9440686
coakley petropoulos whitcomb 2005 assessing vbgemokine coreceptor usage current opinion infectious diseases 9–15 doi1010970000143220050200000003 pmid 15647694
deng ellmeier choe unutmaz burkhart marzio marmon sutton hill davis peiper schall littman landau 1996 identification major coreceptor primary isolates hiv1 nature 6584 661–6 bibcode1996natur381661d doi101038381661a0 pmid 8649511
feng broder kennedy berger 1996 hiv1 entry cofactor functional cdna cloning seventransmembrane proteincoupled receptor science 5263 872–7 bibcode1996sci272872f doi101126science2725263872 pmid 8629022
knight macatonia patterson 1990 infection dendritic cells international review immunology 163–75 doi10310908830189009056627 pmid 2152500
tang kaslow 2003 impact host genetics infection disease progression highly active antiretroviral therapy aids suppl s51–s60 doi1010970000203020031700400006 pmid 15080180
wang koup 1993 genotypic phenotypic characterization hiv1 patients primary infection science 5125 1179–81 bibcode1993sci2611179z doi101126science8356453 pmid 8356453
vant wout kootstra mulderkampinga albrechtvan lent scherpbier veenstra boer coutinho miedema schuitemaker 1994 macrophagetropic variants initiate human immunodeficiency virus type infection sexual parenteral vertical transmission journal clinical investigation 2060–7 doi101172jci117560 294642 pmid 7962552
wang carr moorjankowski cooper 1996 genetic characterization human immunodeficiency virus type blood genital secretions evidence viral compartmentalization selection sexual transmission journal virology 3098–107 190172 pmid 8627789
clevestig maljkovic casper carlenor lindgren navér bohlin fenyö leitner ehrnst 2005 phenotype type evolves children mothers carrying linked transmission aids research human retroviruses 371–8 doi101089aid200521371 pmid 15929699
moore 1997 coreceptors implications pathogenesis therapy science 5309 51–2 doi101126science276530951 pmid 9122710
karlsson parsmyr aperia sandström fenyö albert 1994 cell tropism human immunodeficiency virus type isolates marker response treatment development drug resistance journal infectious diseases 1367–75 doi101093infdis17061367 pmid 7995974
koot wout kootstra goede tersmette schuitemaker 1996 relation changes cellular load evolution viral phenotype clonal composition virus populations course human immunodeficiency virus type infection journal infectious diseases 349–54 doi101093infdis1732349 pmid 8568295
cheney mcknight 2010 hiv2 tropism disease lentiviruses macrophages molecular cellular interactions caister academic press isbn 9781904455608 page needed
chan 1998 entry inhibition cell 681–4 doi101016s0092867400814300 pmid 9630213
wyatt sodroski 1998 hiv1 envelope glycoproteins fusogens antigens immunogens science 5371 1884–8 bibcode1998sci2801884w doi101126science28053711884 pmid 9632381
arthos cicala martinelli macleod xiao veenstra conrad lempicki mclaughlin pascuccio gopaul mcnally cruz censoplano chung reitano kottilil goode fauci 2008 hiv1 envelope protein binds signals integrin alpha4beta7 mucosal homing receptor peripheral cells nature immunology 301–9 doi101038ni1566 pmid 18264102
pope haase 2003 transmission acute hiv1 infection quest strategies prevent infection nature medicine 847–52 doi101038nm0703847 pmid 12835704
haedicke brown naghavi 2009 brainspecific factor fez1 determinant neuronal susceptibility hiv1 infection proceedings national academy sciences 14040–14045 bibcode2009pnas10614040h doi101073pnas0900502106 2729016 pmid 19667186
daecke fackler dittmar kräusslich 2005 involvement clathrinmediated endocytosis human immunodeficiency virus type entry journal virology 1581–1594 doi101128jvi793158115942005 544101 pmid 15650184
miyauchi latinovic morozov melikyan 2009 enters cells endocytosis dynamindependent fusion endosomes cell 433–444 doi101016jcell200902046 2696170 pmid 19410541
koch lampe godinez müller rohr kräusslich lehmann 2009 visualizing fusion pseudotyped hiv1 particles real time live cell microscopy retrovirology doi10118617424690684 2762461 pmid 19765276
thorley mckeating rappoport 2010 mechanis viral entry sneaking front door protoplasma 15–24 doi101007s0070901001526 3038234 pmid 20446005
permanyer ballana esté 2010 endocytosis anything goes trends microbiology 543–551 doi101016jtim201009003 pmid 20965729
zheng lovsin peterlin 2005 newly identified host factors modulate replication immunology letters 225–34 doi101016jimlet200411026 pmid 15752562
viruses animal virus life cycles life cycle kaisers microbiology home page community college baltimore county january 2008 archived original july 2010
hiscott kwon génin 2001 hostile takeovers viral appropriation nfkb pathway journal clinical investigation 143–151 doi101172jci11918 199181 pmid 11160127
pollard malim 1998 hiv1 protein annual review microbiology 491–532 doi101146annurevmicro521491 pmid 9891806
butsch borislawrie 2002 destiny unspliced retroviral ribosome andor virion journal virology 3089–94 doi101128jvi767308930942002 136024 pmid 11884533
hellmund chris lever andrew 20160714 coordination genomic packaging viral assembly hiv1 viruses doi103390v8070192 issn 19994915 4974527 pmid 27428992
ricci herbreteau decimo schaupp datta rein darlix ohlmann 2008 vitro expression hiv2 genomic controlled three distinct internal ribosome entry segments regulated protease polyprotein 1443–55 doi101261rna813608 2441975 pmid 18495939
temin 1990 retroviral recombination reverse transcription science 4985 1227–33 bibcode1990sci2501227h doi101126science1700865 pmid 1700865
charpentier nora tenaillon clavel hance 2006 extensive recombination among human immunodeficiency virus type quasispecies makes important contribution viral diversity individual patients journal virology 2472–82 doi101128jvi805247224822006 1395372 pmid 16474154
nora charpentier tenaillon hoede clavel hance 2007 contribution recombination evolution human immunodeficiency viruses expressing resistance antiretroviral treatment journal virology 7620–8 doi101128jvi0008307 1933369 pmid 17494080
chen powell 2006 high frequency genetic recombination common feature primate lentivirus replication journal virology 9651–8 doi101128jvi0093606 1617242 pmid 16973569
bonhoeffer chappey parkin whitcomb petropoulos 2004 evidence positive epistasis hiv1 science 5701 1547–50 bibcode2004sci3061547b doi101126science1101786 pmid 15567861
israël gougerotpocidalo 1997 oxidative stress human immunodeficiency virus infection cellular molecular life sciences 11–12 864–70 doi101007s000180050106 pmid 9447238
michod bernstein nedelcu 2008 adaptive value microbial pathogens infection genetics evolution 267–85 doi101016jmeegid200801002 pmid 18295550
hallenberger bosch angliker shaw klenk garten november 1992 inhibition furinmediated cleavage activation hiv1 glycoprotein gp160 nature 6402 358–61 bibcode1992natur360358h doi101038360358a0 pmid 1360148
gelderblom 1997 fine structure alamos national laboratory sequence compendium alamos national laboratory 31–44
zhang zhou groppelli pellegrino williams borrow chain jolly 2015 hybrid spreading mechanisms cell activation shape dynamics hiv1 infection plos computational biology e1004179 doi101371journalpcbi1004179 4383537 pmid 25837979
jolly kashefi hollinshead sattentau 2004 hiv1 cell cell transfer across envinduced actindependent synapse journal experimental medicine 283–293 doi101084jem20030648 2211771 pmid 14734528
sattentau 2008 avoiding void celltocell spread human viruses nature reviews microbiology 815–826 doi101038nrmicro1972 pmid 18923409
duncan russell sattentau 2013 high multiplicity hiv1 celltocell transmission macrophages cells limits antiretroviral efficacy aids 2201–2206 doi101097qad0b013e3283632ec4 4714465 pmid 24005480
sewald gonzalez haberman mothes 2012 vivo imaging virological synapses nature communications 1320 doi101038ncomms2338 3784984 pmid 23271654
sigal balazs dekel mayo milo baltimore 2011 celltocell spread permits ongoing replication despite antiretroviral therapy nature 7362 95–98 doi101038nature10347 pmid 21849975
robertson hahn sharp 1995 recombination aids viruses journal molecular evolution 249–59 doi101007bf00163230 pmid 7723052
rambaut posada crandall holmes january 2004 causes consequences evolution nature reviews genetics 52–61 52–61 doi101038nrg1246 pmid 14708016
perelson ribeiro october 2008 estimating drug efficacy viral dynamic parameters statistics medicine 4647–57 doi101002sim3116 pmid 17960579
sodora allan apetrei brenchley douek else estes hahn hirsch kaur kirchhoff mullertrutwin pandrea schmitz silvestri 2009 toward aids vaccine lessons natural simian immunodeficiency virus infections african nonhuman primate hosts nature medicine 861–865 doi101038nm2013 2782707 pmid 19661993
holzammer holznagel kaul kurth norley 2001 high virus loads naturally experimentally sivagminfected african green monkeys virology 324–31 doi101006viro20010870 pmid 11336557
kurth norley 1996 dont natural hosts develop simian aids journal research 33–37
baier dittmar cichutek kurth 1991 development vivo genetic variability simian immunodeficiency virus proceedings national academy sciences united states america 8126–30 bibcode1991pnas888126b doi101073pnas88188126 52459 pmid 1896460
daniel king letvin hunt sehgal desrosiers 1984 type retrovirus isolated macaques immunodeficiency syndrome science 4636 602–5 bibcode1984sci223602d doi101126science6695172 pmid 6695172
keele jones terio estes rudicell wilson learn beasley schumacherstankey wroblewski mosser raphael kamenya lonsdorf travis mlengeya kinsel else silvestri goodall sharp shaw pusey hahn 2009 increased mortality aidslike immunopathology wild chimpanzees infected sivcpz nature 7254 515–519 bibcode2009natur460515k doi101038nature08200 2872475 pmid 19626114
schindler münch kutsch santiago bibolletruche müllertrutwin novembre peeters courgnaud bailes roques sodora silvestri sharp hahn kirchhoff 2006 nefmediated suppression cell activation lost lentiviral lineage gave rise hiv1 cell 1055–67 doi101016jcell200604033 pmid 16777597
thomson pérezalvarez nájera 2002 molecular epidemiology hiv1 genetic forms significance vaccine development therapy lancet infectious diseases 461–471 doi101016s1473309902003432 pmid 12150845
carr foley leitner salminen korber mccutchan 1998 reference sequences representing principal genetic diversity hiv1 pandemic alamos national laboratory sequence compendium alamos mexico alamos national laboratory 10–19 maint uses authors parameter link
osmanov pattou walker schwardländer esparza 2002 estimated global distribution regional spread hiv1 genetic subtypes year 2000 acquired immune deficiency syndrome 184–190 doi1010970004256020020201000013 pmid 11832690
perrin kaiser yerly 2003 travel spread hiv1 genetic variants lancet infectious diseases 22–27 doi101016s1473309903004845 pmid 12505029
plantier leoz dickerson oliveira cordonnier lemée damond robertson simon august 2009 human immunodeficiency virus derived gorillas nature medicine 871–2 doi101038nm2016 pmid 19648927 summary
keele heuverswyn bailes takehisa santiago bibolletruche chen wain liegeois loul ngole bienvenue delaporte brookfield sharp shaw peeters hahn 2006 chimpanzee reservoirs pandemic nonpandemic hiv1 science 5786 523–6 bibcode2006sci313523k doi101126science1126531 2442710 pmid 16728595
kumaranayake watts 2001 resource allocation priority setting hivaids interventions addressing generalized epidemic subsaharan africa journal international development 451–466 doi101002jid797
kleinman september 2004 patient information blood donation transfusion uptodate archived original april 2008
centers disease control prevention 2001 revised guidelines counseling testing referral mmwr recommendations reports rr–19 1–57 pmid 11718472
celum coombs lafferty inui louie gates mccreedy egan grove alexander 1991 indeterminate human immunodeficiency virus type western blots seroconversion risk specificity supplemental tests algorithm evaluation journal infectious diseases 656–664 doi101093infdis1644656 pmid 1894929
country comparison hivaids deaths world factbook central intelligence agency
chou huffman smits korthuis july 2005 screening review evidence preventive services task force annals internal medicine 55–73 doi10732600034819143120050705000010 pmid 15998755
tolle schwarzwald july 2010 postexposure prophylaxis human immunodeficiency virus american family physician 161–6 pmid 20642270
quick reference guide—laboratory testing diagnosis infection updated recommendations cdcgov york state department health june 2014 retrieved april 2017
recommendations testing laboratories cdcgov centers disease control prevention retrieved april 2017
treatment fdaapproved medicines aidsinfo
bernstein ryan lenora brown lenny vaccine trial first years begin chicagotribunecom retrieved 20161128
huang lanzi andrews tsai gajjar seaman padte 2016 engineered bispecific antibodies exquisite hiv1neutralizing activity cell 1621–1631 doi101016jcell201605024 4972332 pmid 27315479
bournazos gazumyan seaman nussenzweig ravetch 2016 bispecific antihiv1 antibodies enhanced breadth potency
attia suzanna egger matthias müller monika zwahlen marcel nicola 2009 sexual transmission according viral load antiretroviral therapy systematic review metaanalysis aids 1397–404 doi101097qad0b013e32832b7dca pmid 19381076
wilson david matthew grulich andrew cooper david kaldor john 2008 relation viral load infectiousness modelbased analysis lancet 9635 314–20 doi101016s0140673608611150 pmid 18657710
cohen myron chen ying mccauley marybeth gamble theresa hosseinipour mina kumarasamy nagalingeswaran hakim james kumwenda johnstone grinsztejn beatriz pilotto jose godbole sheela mehendale sanjay chariyalertsak suwat santos breno mayer kenneth hoffman irving eshleman susan piwowarmanning estelle wang makhema joseph mills lisa bruyn sanne eron joseph gallant joel havlir diane swindells susan ribaudo heather elharrar vanessa 2011 prevention hiv1 infection early antiretroviral therapy england journal medicine 493–505 doi101056nejmoa1105243 3200068 pmid 21767103
consensus statement prevention access campaign november 2017
mandell gerald bennett john dolin raphael 2010 chapter mandell douglas bennetts principles practice infectious diseases philadelphia churchill livingstoneelsevier isbn 9780443068393 page needed
gottlieb 2006 pneumocystis pneumonia—los angeles 1981 american journal public health 980–1 discussion 982–3 doi102105ajph966980 1470612 pmid 16714472 archived original april 2009
friedmankien october 1981 disseminated kaposis sarcoma syndrome young homosexual journal american academy dermatology 468–71 doi101016s0190962281800102 pmid 7287964
hymes cheung greene prose marcus ballard william laubenstein september 1981 kaposis sarcoma homosexual mena report eight cases lancet 8247 598–600 doi101016s0140673681927409 pmid 6116083
basavapathruni anderson december 2007 reverse transcription hiv1 pandemic faseb journal 3795–3808 doi101096fj078697rev pmid 17639073
lederberg joshua 2000 encyclopedia microbiology burlington elsevier isbn 9780080548487 retrieved june 2016
centers disease control 1982 persistent generalized lymphadenopathy among homosexual males morbidity mortality weekly report 249–251 pmid 6808340
barrésinoussi chermann nugeyre chamaret gruest dauguet axlerblin vézinetbrun rouzioux rozenbaum montagnier 1983 isolation tlymphotropic retrovirus patient risk acquired immune deficiency syndrome aids science 4599 868–871 bibcode1983sci220868b doi101126science6189183 pmid 6189183
centers disease control 1982 opportunistic infections kaposis sarcoma among haitians united states morbidity mortality weekly report 353–354 360–361 pmid 6811853
altman 1982 homosexual disorder worries health officials york times retrieved august 2011
gilman sander 1987 aids syphilis iconography disease retrieved april 2015
making headway hellacious circumstances american association advancement science july 2006 retrieved june 2008
kher july 1982 name plague time archived original march 2008 retrieved march 2008
centers disease control 1982 update acquired immune deficiency syndrome aids—united states morbidity mortality weekly report 507–508 513–514 pmid 6815471
gallo sarin gelmann robertguroff richardson kalyanaraman mann sidhu stahl zollapazner leibowitch popovic 1983 isolation human tcell leukemia virus acquired immune deficiency syndrome aids science 4599 865–867 bibcode1983sci220865g doi101126science6601823 pmid 6601823
barrésinoussi chermann nugeyre chamaret gruest dauguet axlerblin vézinetbrun rouzioux rozenbaum montagnier 1983 isolation tlymphotropic retrovirus patient risk acquired immune deficiency syndrome aids science 4599 868–871 bibcode1983sci220868b doi101126science6189183 pmid 6189183
aldrich robert wotherspoon garry 2001 whos lesbian history london routledge isbn 9780415229746
levy 1984 isolation lymphocytopathic retroviruses francisco patients aids science 840–842 doi101126science6206563 maint explicit link
levy kaminsky morrow steimer luciw dina hoxie oshiro 1985 infection retrovirus associated acquired immunodeficiency syndrome annals internal medicine 694–699 doi107326000348191035694 maint multiple names authors list link
sharp hahn 2011 origins aids pandemic cold spring harbor perspectives medicine a006841 doi101101cshperspecta006841 3234451 pmid 22229120
faria rambaut suchard baele bedford ward tatem sousa arinaminpathy pépin posada peeters pybus lemey 2014 early spread epidemic ignition hiv1 human populations science 6205 56–61 doi101126science1256739 4254776 pmid 25278604
bailes robertson chen rodenburg michael cummins arthur peeters shaw sharp hahn 1999 origin hiv1 chimpanzee troglodytes troglodytes nature 6718 436–41 bibcode1999natur397436g doi10103817130 pmid 9989410
keele heuverswyn bailes takehisa santiago bibolletruche chen wain liegeois loul ngole bienvenue delaporte brookfield sharp shaw peeters hahn 2006 chimpanzee reservoirs pandemic nonpandemic hiv1 science 5786 523–6 bibcode2006sci313523k doi101126science1126531 2442710 pmid 16728595
goodier kazazian 2008 retrotransposons revisited restraint rehabilitation parasites cell 23–35 doi101016jcell200809022 pmid 18854152
sharp bailes chaudhuri rodenburg santiago hahn 2001 origins acquired immune deficiency syndrome viruses philosophical transactions royal society 1410 867–76 doi101098rstb20010863 1088480 pmid 11405934
kalish wolfe ndongmo mcnicholl robbins aidoo fonjungo alemnji djoko mpoudingole burke folks 2005 central african hunters exposed simian immunodeficiency virus emerging infectious diseases 1928–30 doi103201eid1112050394 3367631 pmid 16485481
marx alcabes drucker 2001 serial human passage simian immunodeficiency virus unsterile injections emergence epidemic human immunodeficiency virus africa philosophical transactions royal society 1410 911–20 doi101098rstb20010867 1088484 pmid 11405938
worobey gemmel teuwen haselkorn kunstman bunce muyembe kabongo kalengayi marck gilbert wolinsky 2008 direct evidence extensive diversity hiv1 kinshasa 1960 nature 7213 661–4 bibcode2008natur455661w doi101038nature07390 3682493 pmid 18833279
sousa müller lemey vandamme 2010 martin high incidence early 20th century created particularly permissive time window origin initial spread epidemic strains plos e9936 doi101371journalpone0009936 2848574 pmid 20376191
chitnis rawls moore 2000 origin type colonial french equatorial africa aids research human retroviruses doi101089088922200309548 pmid 10628811
donald mcneil september 2010 precursor monkeys millennia york times retrieved september 2010 marx believes crucial event introduction africa millions inexpensive massproduced syringes 1950s suspect growth colonial cities blame 1910 central african town 10000 people urban migration rose increasing sexual contacts leading redlight districts
korber nahmias hooper sharp 1998 african hiv1 sequence 1959 implications origin epidemic nature 6667 594–7 bibcode1998natur391594z doi10103835400 pmid 9468138
kolata gina october 1987 boys 1969 death suggests aids invaded several times york times retrieved february 2009


reading


berlier bourlet lawrence hamzeh lambert genin verrier dieunosjean pozzetto delézay 2005 selective sequestration isolates human genital epithelial cells implication virus tropism selection process sexual transmission journal medical virology 465–74 doi101002jmv20478 pmid 16254974
joint united nations programme hivaids unaids 2011 global hivaids response epidemic update health sector progress towards universal access joint united nations programme hivaids



muciaccia padula vicini gandini lenzi stefanini 2005 betachemokine receptors expressed head region human spermatozoon faseb journal 2048–50 doi101096fj053962fje pmid 16174786

external links

find abouthivat wikipedias sister projects

definitions wiktionary
media wikimedia commons
news wikinews
textbooks wikibooks



hivaids curlie based dmoz












hivaids topics








hivaids













structure genome
subtypes
classification
disease progression rates


hivaids

diagnosis
management
pathophysiology
prevention
research
vaccination
prep


disease staging system infection disease

children
teens adults


countries aids prevalence rate





conditions



signs symptoms
aidsdefining clinical condition
diffuse infiltrative lymphocytosis syndrome
lipodystrophy
nephropathy
neurocognitive disorders
pruritus
superinfection
tuberculosis coinfection
drug resistance database
innate resistance





history



history
epidemiology

multiple partners


timeline
aids museum
timothy brown





social



aids orphan
catholic church hivaids
circumcision
criminal transmission
discrimination people
economic impact
hivaffected community
hivaids denialism
safe
education
list hivpositive people
people aids selfempowerment movement





culture



international aids conference
international aids society
joint united nations programme hivaids unaids
presidents emergency plan aids relief pepfar
treatment action campaign
world aids
media portrayal hivaids
misconceptions hivaids
discredited hivaids origins theories
















aids pandemic region country







africa



angola
benin
botswana
democratic republic congo
egypt
ethiopia
ghana
guinea
côte divoire ivory coast
kenya
lesotho
madagascar
malawi
mali
mozambique
namibia
niger
nigeria
rwanda
senegal
swaziland
tanzania
south africa
uganda
zambia
zimbabwe





north america







canada
mexico
salvador
guatemala
honduras
nicaragua





united states



york city





caribbean



haiti
jamaica
dominican republic








south america



bolivia
brazil
colombia
guyana
peru





asia



bangladesh
bhutan
myanmar burma
cambodia
china yunnan
east timor
india
indonesia
iraq
japan
jordan
laos
nepal
north korea
pakistan
philippines
thailand
taiwan
united arab emirates
vietnam





europe



united kingdom
russia
ukraine





oceania



australia
zealand
papua guinea








list countries hivaids adult prevalence rate
list hivaids cases deaths registered region























sexually transmitted infection primarily a50–a64 090–099



bacterial



chancroid haemophilus ducreyi
chlamydialymphogranuloma venereum chlamydia trachomatis
donovanosis granuloma inguinale klebsiella granulomatis
gonorrhea neisseria gonorrhoeae
mycoplasma hominis infection mycoplasma hominis
syphilis treponema pallidum
ureaplasma infection ureaplasma urealyticum





protozoal



trichomoniasis trichomonas vaginalis





parasitic



crab lousecrabs
scabies





viral



aids hiv1hiv2
cervical cancer vulvar cancer genital warts condyloma penile cancer anal cancer human papillomavirus
hepatitis hepatitis virus
herpes simplex hsv1hsv2
molluscum contagiosum





general
inflammation



female
cervicitis
pelvic inflammatory disease


male
epididymitis
prostatitis


either
proctitis
urethritisnongonococcal urethritis

















virus retroviruses



ssrnart virus




retroviridae




alpharetrovirus



avian sarcoma leukosis virus
rous sarcoma virus





betaretrovirus



mouse mammary tumor virus
jaagsiekte sheep retrovirus





deltaretrovirus



human tlymphotropic virus htlv1
htlv2
simiantlymphotropic virus types
bovine leukemia virus





epsilonretrovirus



walleye epidermal hyperplasia virus





gammaretrovirus



murine leukemia virus
abelson murine leukemia virus
friend virus
feline leukemia virus
koala retrovirus kids
xenotropic murine leukemia virusrelated virus





lentivirus




simian immunodeficiency virus
feline immunodeficiency virus
puma lentivirus
equine infectious anemia
bovine immunodeficiency virus
caprine arthritis encephalitis virus
visna virus





spumavirus



simian foamy virus
human foamy virus












metaviridae
pseudoviridae








dsdnart virus



hepadnaviridae hepatitis virus
caulimoviridae





endogenous



ervwe1
hcp5
human teratocarcinomaderived virus

















breakthrough year



science
journal



1996 understanding
1997 dolly sheep
1998 accelerating universe
1999 stem cell
2000 whole genome sequencing
2001 nanocircuits molecular circuit
2002 interference
2003 dark energy
2004 spirit rover
2005 evolution action
2006 poincaré conjecture proof
2007 human genetic variation
2008 cellular reprogramming
2009 ardipithecus ramidus
2010 first quantum machine
2011 hptn clinical trial
2012 higgs boson discovery
2013 cancer immunotherapy
2014 rosetta comet mission
2015 crispr genomeediting method
2016 first observation gravitational waves
2017 gw170817 neutron star merger









authority control



lccn sh86004391
42007926
sudoc 028936868
cb12066922x data
xx534964











retrieved httpsenwikipediaorgwindexphptitlehivoldid816306086 categories hivaidscauses deathdiscovery invention controversiesiarc group carcinogenslentivirusessexually transmitted diseases infectionshidden categories wikipedia articles needing page number citations december 2017cs1 maint uses authors parametercs1 maint explicit alcs1 maint multiple names authors listwikipedia indefinitely semiprotected pagesgood articlesuse dates june 2013articles species microformatsall articles failed verificationarticles failed verification april 2014all articles unsourced statementsarticles unsourced statements february 2015articles unsourced statements november 2014wikipedia articles need updating january 2013all wikipedia articles need updatingarticles dmoz linkswikipedia articles lccn identifierswikipedia articles identifierswikipedia articles identifiers
